Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 5.07M | 72.82% | $ 6.96M |
3/31/2025 | $ 4.65M | 105.23% | $ 4.42M |
12/31/2024 | $ 3.83M | 135.83% | $ 2.82M |
9/30/2024 | $ 3.41M | 36.38% | $ 9.36M |
6/30/2024 | $ 3.46M | 28.32% | $ 12.2M |
3/31/2024 | $ 3.01M | 20.34% | $ 14.81M |
12/31/2023 | $ 3.15M | 14.95% | $ 21.05M |
9/30/2023 | $ 4.05M | 23.94% | $ 16.93M |
6/30/2023 | $ 3.06M | 18.64% | $ 16.41M |
3/31/2023 | $ 4.53M | 26.17% | $ 17.32M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / Revenues
(=) CapEx %
CapEx % for TSCAN THERAPEUTICS INC is calculated as follows: CapEx [ $ 4.24M ] / Revenues [ $ 1.08M ]
(=) CapEx % [ 390.6% ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.85K |
---|---|
min | 0% |
max | 15.04% |
average | 3.46% |
median | 2.43% |
std | 3.27% |